Amidefrine
Drug profile
Also known as: (+/-)-Amidephrine, amidefrine mesilate, amidefrine mesylate, amidephrine, amidephrine mesilate, amidephrine mesylate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Amidefrine is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including Adra2b|Adra2c|Adra2a and Adra1b|Adra1d|Adra1a.
- Molecular targets: Adra2b|Adra2c|Adra2a and Adra1b|Adra1d|Adra1a (2 listed in DrugCentral).
- Molecular formula: C10H16N2O3S; molecular weight 244.31 g/mol.
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Adrenergic receptor alpha-2 | Adra2b|Adra2c|Adra2a | unknown | IC50 4.72 |
| Adrenergic receptor alpha-1 | Adra1b|Adra1d|Adra1a | unknown | IC50 4.40 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Amidefrine is on its molecule page.
| Molecular formula | C10H16N2O3S |
|---|---|
| Molecular weight | 244.31 g/mol |
| CAS number | 37571-84-9 |
| InChIKey | ZHOWHMXTJFZXRB-UHFFFAOYSA-N |
| PubChem CID | 15010 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Amidefrine work?
Its molecular targets in DrugCentral include Adra2b|Adra2c|Adra2a and Adra1b|Adra1d|Adra1a.
What is the chemical formula of Amidefrine?
Amidefrine has the molecular formula C10H16N2O3S and a molecular weight of 244.31 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 155 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL146408 — compound record and bioactivity
- PubChem CID 15010 — chemical identifiers
- DrugBank DB16623 — drug record
- FDA UNII 7E2P22546V — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.